Deletion of a Distal RANKL Gene Enhancer Delays Progression of Atherosclerotic Plaque Calcification in Hypercholesterolemic Mice

被引:3
|
作者
Shamsuzzaman, Sohel [1 ]
Onal, Melda [1 ]
St John, Hillary C. [1 ]
Pike, J. Wesley [1 ]
机构
[1] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA
关键词
RANKL; DISTAL ENHANCER; ATHEROSCLEROTIC PLAQUE; mu CT; PLAQUE CALCIFICATION; GENE REGULATION; PLAQUE RANKL; KAPPA-B LIGAND; SMOOTH-MUSCLE-CELLS; OSTEOCLAST DIFFERENTIATION FACTOR; TISSUE-SPECIFIC EXPRESSION; VITAMIN-D-RECEPTOR; VASCULAR CALCIFICATION; ARTERIAL CALCIFICATION; BONE LOSS; TNFSF11; GENE; T-CELLS;
D O I
10.1002/jcb.26074
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Receptor activator of NF-B ligand (RANKL) is a TNF-like cytokine which mediates diverse physiological functions including bone remodeling and immune regulation. RANKL has been identified in atherosclerotic lesions; however, its role in atherosclerotic plaque development remains elusive. An enhancer located 75kb upstream of the murine Rankl gene's transcription start site designated D5 is important for its calciotropic hormone- and cytokine-mediated expression. Here, we determined the impact of RANKL levels in atherosclerotic plaque development in the D5 enhancer-null (D5(-/-)) mice in an atherogenic Apoe(-/-) background fed a high-fat diet (HFD). Rankl mRNA transcripts were increased in aortic arches and thoracic aortae of Apoe(-/-) mice; however, this increase was blunted in Apoe(-/-);D5(-/-) mice. Similarly, higher Rankl transcripts were identified in splenic T lymphocytes in Apoe(-/-) mice, and their levels were reduced in Apoe(-/-);D5(-/-) mice. When analyzed by micro-computed tomography (mu CT), atherosclerotic plaque calcification was identified in six out of eight Apoe(-/-) mice, whereas only one out of eight Apoe(-/-);D5(-/-) mice developed plaque calcification after 12 weeks of HFD. However, following 18 weeks of HFD challenge, all of Apoe(-/-) and Apoe(-/-);D5(-/-) animals developed atherosclerotic plaque calcification. Likewise, atherosclerotic lesion sizes were site-specifically reduced in the aortic arch of Apoe(-/-);D5(-/-) mice at initial stage of atherosclerosis and this effect was diminished as atherosclerosis proceeded to a more advanced stage. Our data suggest that deletion of the RANKL D5 enhancer delays the progression of atherosclerotic plaque development and plaque calcification in hypercholesterolemic mice. This work provides important insight into RANKL's regulatory role in atherosclerosis. J. Cell. Biochem. 118: 4240-4253, 2017. (c) 2017 Wiley Periodicals, Inc.
引用
收藏
页码:4240 / 4253
页数:14
相关论文
共 50 条
  • [11] Oral rapamycin attenuates atherosclerotic plaque progression in ApoE knockout mice
    Pakala, R
    Stabile, E
    Finegold, AA
    Hellinga, D
    Seabron, R
    Baffour, R
    Waksman, R
    CIRCULATION, 2004, 110 (17) : 53 - 53
  • [12] Role of CaMKII in Atherosclerotic Plaque Progression in ApoE-Deficient Mice
    Ebenebe, Obialunanma V.
    Heather, Alison K.
    Erickson, Jeffrey R.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [13] Rosuvastatin attenuates the progression of atherosclerotic plaque formation in ApoE-/- mice
    Du, Xiu-Wen
    Gao, Cai
    Han, You-Wei
    Liu, Xiao-Xia
    Wang, Lin
    Jiang, Hong-Ju
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (06): : 9056 - 9064
  • [14] Paradoxical Effects of Overexpressing Human Catalase on Vascular Function and Atherosclerotic Plaque Composition in Hypercholesterolemic Mice
    Roos, Benjamin B.
    Roos, Carolyn M.
    Hagler, Michael A.
    Zhang, Bin
    Miller, Jordan D.
    FASEB JOURNAL, 2018, 32 (01):
  • [15] Apixaban versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque (A Prospective Randomized Trial)
    Win, Theingi Tiffany
    Nakanishi, Rine
    Osawa, Kazuhiro
    Li, Dong
    Susaria, Shriraj
    Jayawardena, Eranthi
    Hamal, Sajad
    Kim, Michael
    Broersen, Alexander
    Kitslaar, Pieter
    Dailing, Christopher
    Budoff, Matthew J.
    CIRCULATION, 2017, 136
  • [16] Teriparatide administration is osteoanabolic but does not impact atherosclerotic plaque calcification and progression in a mouse model of menopause
    Bessueille, Laurence
    Briolay, Anne
    Guillot, Nicolas
    Mebarek, Saida
    Viallon, Solene
    Laroche, Norbert
    Lafage-Proust, Marie-Helene
    Magne, David
    BONE, 2025, 190
  • [17] TERIPARATIDE ADMINISTRATION IS OSTEOANABOLIC BUT DOES NOT IMPACT ATHEROSCLEROTIC PLAQUE CALCIFICATION AND PROGRESSION IN A MOUSE MODEL OF MENOPAUSE
    Bessueille, Laurence
    Briolay, Anne
    Guillot, Nicolas
    Mebarek, Saida
    Viallon, Solene
    Lafage-Proust, Marie-Helene
    Magne, David
    ATHEROSCLEROSIS, 2024, 395
  • [18] Reduced atherosclerotic plaque burden in mice with targeted deletion of the discoidin domain receptor 1 (DDR1) gene
    Franco, C
    Hou, GP
    Bendeck, MP
    FASEB JOURNAL, 2006, 20 (04): : A12 - A12
  • [19] Physical training and metabolic supplementation reduce spontaneous atherosclerotic plaque rupture and prolong survival in hypercholesterolemic mice
    Napoli, Claudio
    Williams-Ignarron, Sharon
    de Nigris, Filomena
    Lerman, Lilach O.
    D'Armiento, Francesco P.
    Crimi, Ettore
    Byrns, Russell E.
    Casamassimi, Amelia
    Lanza, Alessandro
    Gombos, Fernando
    Sica, Vincenzo
    Ignarro, Louis J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (27) : 10479 - 10484
  • [20] The effect of clopidogrel on atherosclerotic plaque progression and rupture in apolipoprotein E knockout mice
    Williams, H
    Baker, N
    Poole, A
    Jackson, CL
    ATHEROSCLEROSIS, 2005, 181 (01) : S6 - S6